User profiles for Y.C. Park

Yong-Cheol Park

Professor, Kookmin University, Seoul, Korea
Verified email at kookmin.ac.kr
Cited by 4297

All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction

JY Chung, YC Park, H Ye, H Wu - Journal of cell science, 2002 - journals.biologists.com
The tumor necrosis factor (TNF) receptor associated factors (TRAFs) have emerged as the
major signal transducers for the TNF receptor superfamily and the interleukin-1 receptor/Toll-…

Strain engineering of Saccharomyces cerevisiae for enhanced xylose metabolism

SR Kim, YC Park, YS Jin, JH Seo - Biotechnology advances, 2013 - Elsevier
Efficient and rapid fermentation of all sugars present in cellulosic hydrolysates is essential for
economic conversion of renewable biomass into fuels and chemicals. Xylose is one of the …

Korean growth policy

R Dornbusch, YC Park, SM Collins, V Corbo - Brookings Papers on …, 1987 - JSTOR
… from Won-Am Park, Sung-Hee Jwa, and Choong-Soo Kim of the Korea Development Institute.
This paper was prepared while Yung Chul Park was with the Korea Development Institute. …

[HTML][HTML] Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer

…, P De Porre, T Kheoh, YC Park… - … England Journal of …, 2017 - Mass Medical Soc
Background Abiraterone acetate, a drug that blocks endogenous androgen synthesis, plus
prednisone is indicated for metastatic castration-resistant prostate cancer. We evaluated the …

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302) …

…, TW Griffin, P De Porre, KY Margaret, YC Park… - The Lancet …, 2015 - thelancet.com
Background Abiraterone acetate plus prednisone significantly improved radiographic
progression-free survival compared with placebo plus prednisone in men with chemotherapy-…

Structural basis for self-association and receptor recognition of human TRAF2

YC Park, V Burkitt, AR Villa, L Tong, H Wu - Nature, 1999 - nature.com
Tumour necrosis factor (TNF)-receptor-associated factors (TRAFs) form a family of
cytoplasmic adapter proteins that mediate signal transduction from many members of the TNF-…

[HTML][HTML] Apalutamide treatment and metastasis-free survival in prostate cancer

…, GC Trudel, BM Espina, Y Shu, YC Park… - … England Journal of …, 2018 - Mass Medical Soc
Background Apalutamide, a competitive inhibitor of the androgen receptor, is under development
for the treatment of prostate cancer. We evaluated the efficacy of apalutamide in men …

[HTML][HTML] A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD–TRAF2 interaction

YC Park, H Ye, C Hsia, D Segal, RL Rich, HC Liou… - Cell, 2000 - cell.com
TRAF proteins are major mediators for the cell activation, cell survival, and antiapoptotic
functions of the TNF receptor superfamily. They can be recruited to activated TNF receptors …

[HTML][HTML] Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain

Y Huang, YC Park, RL Rich, D Segal, DG Myszka… - Cell, 2001 - cell.com
The inhibitor of apoptosis proteins (IAPs) represent the only endogenous caspase inhibitors
and are characterized by the presence of baculoviral IAP repeats (BIRs). Here, we report the …

[PDF][PDF] The structural basis for the recognition of diverse receptor sequences by TRAF2

H Ye, YC Park, M Kreishman, E Kieff, H Wu - Molecular cell, 1999 - cell.com
… All the receptor peptides were chemically synthesized human TRAF2, both alone and in
complex with a TNFR2 peptide (Park et al., … terminus in the peptide used in the study (Park et al., …